English
Aarti Drugs Q1 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
370.85
-4.00 (-1.07%)
-4.00 (-1.07%)Volume1.82 K
Updated: Fri 23 Jan, 2026 | 15:10:43
NSE
370.05-5.65 (-1.50%)
-5.65 (-1.50%)Volume1.02 L
Updated: Fri 23 Jan, 2026 | 15:40:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Aarti Drugs Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 531.15 | 598.32 | -11.23% | 503.76 | 5.44% |
| Depreciation/ Amortization | 14.72 | 14.88 | -1.05% | 13.38 | 10.01% |
| Operating Income | 59.36 | 78.44 | -24.33% | 51.58 | 15.08% |
| Net Income | 53.91 | 62.86 | -14.24% | 33.24 | 62.17% |
| Other Operating Expenses Total | 112.24 | 115.19 | -2.56% | 104.13 | 7.79% |
| Net Income Before Taxes | 51.11 | 71.15 | -28.17% | 43.98 | 16.21% |
| Total Revenue | 590.51 | 676.76 | -12.74% | 555.34 | 6.33% |
| Selling/ General/ Admin Expenses Total | 30.80 | 31.35 | -1.75% | 26.43 | 16.53% |
| Diluted Normalized EPS | 5.91 | 6.77 | -12.74% | 3.62 | 63.26% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.